Area of research
Hematology · Molecular Biology
Research interest
Research focused on Myeloid leukemia and Cancer research, with related work in Enhancer, CEBPA, MYB. Notable publications include 'Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia', 'Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2', and 'MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia'.